US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 22.895
  • -0.205-0.89%
Trading Mar 11 09:57 ET
1.06BMarket Cap-10.65P/E (TTM)

Pacira BioSciences Key Stats

Pacira BioSciences Q4 2024 Earnings Date

Currency:USDFeb 27, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
185.38M
187.25M
+1.87M
Beat Est.
+2.28%
+3.32%
+1.01%
EPS
0.39
0.34
-0.05
Miss Est.
-22.00%
-34.62%
-12.82%
Buy

Mar 11, 2025

Pacira BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 187.112M--
--2025/Q1-- / 175.603M--
Feb 27, 20252024/Q4187.253M / 185.382M--
Nov 6, 20242024/Q3168.573M / 169.506M--
Jul 30, 20242024/Q2178.023M / 173.684M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 187.112M--
--2025/Q1-- / 175.603M--
Feb 27, 20252024/Q4187.253M / 185.382M--
Nov 6, 20242024/Q3168.573M / 169.506M--
Jul 30, 20242024/Q2178.023M / 173.684M--

Unlock Free Earnings Estimates

Pacira BioSciences Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 11, 2025

Buy

  • Buy

    42.86%
  • Hold

    42.86%
  • Sell

    14.29%

Price Target

No Data